Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Infusion Biosciences is a biotechnology company focused on the discovery and commercialization of proprietary technologies for the cannabis and hemp industries. The company is best known for its Aqueous Phytorecovery Process (APP), a patent-pending technology that recovers water-soluble cannabinoids and terpenes directly from the plant material into a water-based solution. This platform enables the production of fast-acting, water-soluble cannabis ingredients for beverages and edibles without the need for synthetic emulsifiers or nano-encapsulation. Infusion Biosciences operates primarily through licensing agreements, providing its specialized extracts to consumer packaged goods companies in the legal cannabis and hemp-derived CBD markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Infusion Biosciences Canada.